Since the murine model of premalignant lesions that progress to HNSCC exhibited a similar immune phenotype as seen with human tissues, the model was used to further investigate the modulation of IL17 production by premalignant lesions and HNSCC. The gene discussed is IL17A; the disease is head and neck squamous cell carcinoma.